COMPANY

Iaterion, Inc.

Iaterion’s current focus is derived from Dr. Cohen’s targeted screening approach for discovering drugs to treat and prevent diseases. From company website Source · Oct 13, 2026

Keywords: oncology

Profile checked Oct 10, 2026

3NIH grants

NIH awards 3

Annual award amounts. Total $735K.

Aug 23, 2023 NIH award 1R43AG084372-01 FY2023: $298,883 awarded for that fiscal year; activity R43 (SBIR); PI LEITMAN, DALE C; recipient as written: IATERION, INC., OAKLAND, CA. Estrogen receptor reprogramming ligands for the pre source ↗
Aug 25, 2021 NIH award 1R43AG072965-01 FY2021: $255,543 awarded for that fiscal year; activity R43 (SBIR); PI LEITMAN, DALE C; recipient as written: IATERION, INC., OAKLAND, CA. Development of reprogramming ligands for menopausal source ↗
Sep 22, 2016 NIH award 1R43DK109862-01 FY2016: $180,129 awarded for that fiscal year; activity R43 (SBIR); PI LEITMAN, DALE C; recipient as written: IATERION, INC., OAKLAND, CA. Estrogen Receptor Coligand Reprogramming of Menopau source ↗